Detalles de la búsqueda
1.
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis.
Rheumatol Int
; 44(4): 603-610, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300269
2.
Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series.
Ann Rheum Dis
; 2022 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701154
3.
Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment.
Pathog Immun
; 5(1): 34-51, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32258853
4.
Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis.
Front Med (Lausanne)
; 7: 288, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32637422
5.
Five-year prospective multi-center cohort study of patients with giant cell arteritis in Greece.
Mediterr J Rheumatol
; 29(2): 103-105, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185310
6.
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
Semin Arthritis Rheum
; 48(3): 467-474, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29555348
7.
Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients.
Front Immunol
; 8: 1967, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29375580
Resultados
1 -
7
de 7
1
Próxima >
>>